Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia.

Source:http://linkedlifedata.com/resource/pubmed/id/17881973

Download in:

View as

General Info

PMID
17881973